Partner Content Partner Content How Will Spark’s Approval Impact the Gene Therapy Field? Gene Therapy for Rare Disorders Summit
Partner Content Partner Content 7th Annual HPAPI Summit - Boston 2018 Explore Unique Potent Compound Case Studies
Partner Content Partner Content Microbiome Drug Development Boston - Your Invite Pioneering The Microbiome Into Effective Medicines
Events Partner Content Microbiome Drug Development Boston 2018 Pioneering The Microbiome Into Effective Medicines
Debates & Insight Sponsored Standing on the cusp of something great: How real-world data... REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care
Events Partner Content Personalized and Precision Medicine International Conference... Int. Conference on Personalized and Precision Medicine
News Sanofi's bispecific lunsekimig has mixed readouts in phase 2 Sanofi's IL-13 and TSLP-targeting bispecific lunsekimig wins two, loses one, in readouts from its midstage clinical trials programme.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
